2011Journal of Experimental HematologyRequires access

New Concept for ALK Negative Anaplastic Large Cell Lymphoma——Review

Tang Xiao

Open publisher page 0 citations

Abstract

ALK negative anaplastic large cell lymphoma(ALK-ALCL) lacks the specific expression of ALK protein,although it also strongly expresses CD30 and resembles the morphologic characteristics of ALK positive anaplastic large cell lymphoma(ALK+ ALCL).Recently,some new researches indicate that there exist molecular and genetic differences between these two types of ALCL.Moreover,the treatment response,prognosis,and long-term survival of ALK-ALCL are far worse than that of ALK+ ALCL,such as ALK-ALCL is associated with older age persons,B group syndrome,disease advanced stage,high International Prognostic Index(IPI) and poor prognosis(49% 5-year survival).As a consequence,some new advances on basis(cell morphology and tissue pathology,immunophenotypes,cell genetics and molecular marker),diagnosis and treatment of ALK-ALCL are summrized in this review.

About this research paper

What this paper is about

ALK negative anaplastic large cell lymphoma(ALK-ALCL) lacks the specific expression of ALK protein,although it also strongly expresses CD30 and resembles the morphologic characteristics of ALK positive anaplastic large cell lymphoma(ALK+ ALCL).Recently,some new researches indicate that there exist molecular and genetic differences between these two types of ALCL.Moreover,the treatment response,prognosis,and long-term survival of ALK-ALCL are far worse than that of ALK+ ALCL,such as ALK-ALCL is associated with older age persons,B group syndrome,disease advanced stage,high International Prognostic Index(IPI) and poor prognosis(49% 5-year survival).As a consequence,some new advances on basis(cell morphology and tissue pathology,immunophenotypes,cell genetics and molecular marker),diagnosis and treatment of ALK-ALCL are summrized in this review.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ALK negative anaplastic large cell lymphoma(ALK-ALCL) lacks the specific expression of ALK protein,although it also strongly expresses CD30 and resembles the morphologic characteristics of ALK positive anaplastic large cell lymphoma(ALK+ ALCL).Recently,some new researches indicate that there exist molecular and genetic differences between these two types of ALCL.Moreover,the treatment response,prognosis,and long-term survival of ALK-ALCL are far worse than that of ALK+ ALCL,such as ALK-ALCL is associated with older age persons,B group syndrome,disease advanced stage,high International Prognostic Index(IPI) and poor prognosis(49% 5-year survival).As a consequence,some new advances on basis(cell morphology and tissue pathology,immunophenotypes,cell genetics and molecular marker),diagnosis and treatment of ALK-ALCL are summrized in this review.

Key concepts: Anaplastic large-cell lymphoma, Anaplastic lymphoma kinase, CD30, Lymphoma, Large cell, Cancer research, Pathology, Stage (stratigraphy)

Related papers

Back to paper searchBrowse research topicsOriginal source
New Concept for ALK Negative Anaplastic Large Cell Lymphoma——Review — Research Paper | ScholarLens